REGULATION OF PAX3/PAX7 EXPRESSION IN RHABDOMYOSARCOMA
REGULATION OF PAX3/PAX7 EXPRESSION IN RHABDOMYOSARCOMA
批准号:
6362612
负责人:
FREDERIC G BARR
金额:
$24.05万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2003-02-28
中文摘要
描述:(改编自研究者摘要)PAX 3和PAX 7是
转录因子的配对盒家族中密切相关的成员。
基因产物以重叠但不同的模式表达
在骨骼肌谱系的形成过程中,
调节生长、分化和运动。 儿科研究
癌腺泡状横纹肌肉瘤(ARMS)已经证明PAX 3和PAX 7
在涉及骨骼肌的肿瘤发展中起重要作用
脉 在ARMS中,PAX 3或PAX 7基因通过融合蛋白与FKHR基因融合。
t(2;13)或t(1;13)染色体易位,
具有假定致癌活性的转录激活因子。 此外
对于这些功能改变,初步实验已经揭示了
改变ARMS中PAX 3和PAX 7表达的不同机制;
t(1;13)易位与重排的
PAX 7基因,而t(2;13)易位与
重排的PAX 3基因的过表达而没有扩增。 研究
胚胎性横纹肌肉瘤(ERMS),第二种儿科癌症,
肌源性谱系,揭示了野生型PAX 7表达的差异
ERMS和ARMS之间的差异,从而表明肿瘤特异性差异,
各自的转录环境。 为了定义PAX 3的模式,
PAX 7在ARMS和ERMS中的表达,并阐明其差异或
表达、RNA和蛋白质表达的改变将在
肿瘤线和标本。 作为阐明基因和
肿瘤特异性表达特征,将进行实验以
确定染色质特征在长距离基因组图谱上的位置,
PAX 3和PAX 7基因座。 这些资源将用于
鉴定调节细胞凋亡的顺式作用元件的转染试验
PAX 3和PAX 7在这些肿瘤中的表达。 对于那些顺式作用元件
它们负责改变重排基因的表达,
ERMS和ARMS之间的差异表达,
反式作用因子将通过DNA结合和转录水平来研究
测定。 因此,这些研究将结合联合收割机的mRNA检测,基因组
定位和转录方法来定义模式和分子
在这些肿瘤中控制PAX 3和PAX 7表达的基础,提供了
用于理解它们在正常骨骼肌中表达的模型
发展,并最终使战略的设计,以操纵
这些基因的表达。
英文摘要
DESCRIPTION: (adapted from the investigator's abstract) PAX3 and PAX7 are
closely related members of the paired box family of transcription factors.
The gene products are expressed with overlapping yet distinct patterns
during formation of the skeletal muscle lineage and have important roles in
regulating growth, differentiation, and motility. Studies of the pediatric
cancer alveolar rhabdomyosarcoma (ARMS) have demonstrated that PAX3 and PAX7
play important roles in neoplastic develpment involving the skeletal muscle
lineage. In ARMS, the PAX 3 or PAX7 gene is fused to the FKHR gene by the
t(2;13) or t(1;13) chromosomal translocation to created potent
transcriptional activators with postulated oncogenic activity. In addition
to these functional alterations, preliminary experiments have revealed
distinct mechanisms for altering PAX3 and PAX7 expression in ARMS; the
t(1;13) translocation is associated with amplification of the rearranged
PAX7 gene, whereas the t(2;13) translocation is associated with
overexpression of the rearranged PAX3 gene without amplification. Studies
of embryonal rhabdomyosarcoma (ERMS), a second pediatric cancer related to
the myogenic lineage, have revealed differences in wild-type PAX7 expression
between ERMS and ARMS, and thus suggest tumor-specific differences in the
respective transcriptional environments. To define the patterns of PAX3 and
PAX7 expression in ARMS and ERMS, and elucidate the differences or
alterations in expression, RNA and protein expression will be assaysed in
tumor lines and specimens. As a starting-point for elucidating gene-and
tumor-specific expression features, experiments will be conducted to
determine the location of chromatin features on long-range genomic maps of
the PAX3 and PAX7 loci. These resources will then be utilized in
reporter-transfection assays to identify cis-acting elements that regulate
PAX3 and PAX7 expression in these tumors. For those cis-acting elements
which are responsible for altered expression of the rearranged genes or
differential expression between ERMS and ARMS, the corresponding
trans-acting factors will be studies by DNA binding and transcriptional
assays. These studies will therefore combine mRNA detection, genomic
mapping, and transcriptional approaches to define the pattern and molecular
basis for control of PAX3 and PAX7 expression in these tumors, provide
models for understanding their expression during normal skeletal muscle
development, and ultimately enable the design of strategies to manipulate
expression of these genes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
1999-11
期刊:
Cancer research
影响因子:
11.2
作者:
[F. Barr;J. Fitzgerald;J. Ginsberg;Michelle L. Vanella;Richard J. Davis;J. Bennicelli]
通讯作者:
F. Barr;J. Fitzgerald;J. Ginsberg;Michelle L. Vanella;Richard J. Davis;J. Bennicelli
DNA methylation-based assays for detecting disease spread in rhabdomyosarcoma
-
批准号:7875543
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2010
-
负责人:FREDERIC G BARR
-
依托单位:
COG studies of gene amplification in rhabdomyosarcoma
-
批准号:7910236
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2009
-
负责人:FREDERIC G BARR
-
依托单位:
COG studies of gene amplification in rhabdomyosarcoma
-
批准号:7233681
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2005
-
负责人:FREDERIC G BARR
-
依托单位:
COG studies of gene amplification in rhabdomyosarcoma
-
批准号:7431756
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2005
-
负责人:FREDERIC G BARR
-
依托单位:
COG studies of gene amplification in rhabdomyosarcoma
-
批准号:7103702
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2005
-
负责人:FREDERIC G BARR
-
依托单位:
COG studies of gene amplification in rhabdomyosarcoma
-
批准号:6969858
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2005
-
负责人:FREDERIC G BARR
-
依托单位:
Cancer Molecular Pathology Training Program
-
批准号:6399509
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS
-
批准号:6628497
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
Cancer Molecular Pathology Training Program
-
批准号:6514695
-
项目类别:
-
资助金额:$36.19万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS
-
批准号:6701283
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS
-
批准号:6847445
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS
-
批准号:6232397
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS
-
批准号:6498051
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
Cancer Molecular Pathology Training Program
-
批准号:6633809
-
项目类别:
-
资助金额:$22.06万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
Cancer Molecular Pathology Training Program
-
批准号:6919931
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
Cancer Molecular Pathology Training Program
-
批准号:7123849
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
Cancer Molecular Pathology Training Program
-
批准号:6798651
-
项目类别:
-
资助金额:$61.59万
-
财政年份:2001
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG LABORATORY CORRELATIVE STUDIES
-
批准号:2896796
-
项目类别:
-
资助金额:$19.62万
-
财政年份:1998
-
负责人:FREDERIC G BARR
-
依托单位:
IRSG LABORATORY CORRELATIVE STUDIES
-
批准号:2859817
-
项目类别:
-
资助金额:$24.77万
-
财政年份:1998
-
负责人:FREDERIC G BARR
-
依托单位:
REGULATION OF PAX3/PAX7 EXPRESSION IN RHABDOMYOSARCOMA
-
批准号:2882457
-
项目类别:
-
资助金额:$22.81万
-
财政年份:1997
-
负责人:FREDERIC G BARR
-
依托单位: